DK0740550T3 - Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger - Google Patents

Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger

Info

Publication number: DK0740550T3
Authority: DK; Denmark
Prior art keywords: treatment; respiratory; lung diseases; allergic; mometasone
Prior art date: 1994-01-27

Application number

DK95909242T

Other languages

English (en)

Inventor

Francis M Cuss

Imtiaz A Chaudry

Nagamani Nagabhushan

Joel A Sequeira

Keith B Nolop

James E Patrick

Mitchell Cayen

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-27

Filing date

1995-01-26

Publication date

2002-06-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22692858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0740550(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-01-26 Application filed by Schering Corp filed Critical Schering Corp

2002-06-24 Application granted granted Critical

2002-06-24 Publication of DK0740550T3 publication Critical patent/DK0740550T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK95909242T 1994-01-27 1995-01-26 Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger DK0740550T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18837294A	1994-01-27	1994-01-27
PCT/US1995/000550 WO1995020393A1 (en)	1994-01-27	1995-01-26	Use of mometasone furoate for treating airway passage and lung diseases

Publications (1)

Publication Number	Publication Date
DK0740550T3 true DK0740550T3 (da)	2002-06-24

Family

ID=22692858

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK95909242T DK0740550T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger
DK09007995.5T DK2156840T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme
DK01119613.6T DK1174138T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK09007995.5T DK2156840T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme
DK01119613.6T DK1174138T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme

Country Status (29)

Country	Link
EP (6)	EP2156840B1 (da)
JP (6)	JP3480736B2 (da)
KR (1)	KR100234864B1 (da)
CN (4)	CN100358528C (da)
AT (5)	ATE525075T1 (da)
AU (1)	AU691880B2 (da)
CA (1)	CA2182086C (da)
CO (1)	CO4340692A1 (da)
CY (2)	CY2617B2 (da)
CZ (1)	CZ219196A3 (da)
DE (1)	DE69526425T2 (da)
DK (3)	DK0740550T3 (da)
ES (3)	ES2369516T3 (da)
FI (2)	FI122395B (da)
HK (4)	HK1040912A1 (da)
HU (1)	HU227837B1 (da)
IL (1)	IL112459A (da)
MX (1)	MX9602246A (da)
MY (1)	MY114665A (da)
NO (2)	NO314535B1 (da)
NZ (1)	NZ279979A (da)
PE (1)	PE44995A1 (da)
PL (1)	PL315575A1 (da)
PT (3)	PT2156840E (da)
SG (1)	SG47387A1 (da)
SK (1)	SK283338B6 (da)
TW (1)	TW329387B (da)
WO (1)	WO1995020393A1 (da)
ZA (1)	ZA95637B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
DE69731473T2 (de) *	1996-05-09	2005-10-27	Amrad Operations Pty. Ltd., Richmond	Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen
CZ294064B6 (cs) *	1996-08-29	2004-09-15	Schering Corporation	Aerosolový suspenzní přípravek mometazonfuroátu bez chlorfluorovaných uhlovodíků
US6068832A (en) *	1996-08-29	2000-05-30	Schering Corporation	Chlorofluorocarbon-free mometasone furoate aerosol formulations
US5968547A (en)	1997-02-24	1999-10-19	Euro-Celtique, S.A.	Method of providing sustained analgesia with buprenorphine
ATE284677T1 (de) *	1997-03-20	2005-01-15	Schering Corp	Herstellung von pulveragglomeraten
US6495167B2 (en)	1997-03-20	2002-12-17	Schering Corporation	Preparation of powder agglomerates
US6503537B2 (en)	1997-03-20	2003-01-07	Schering Corporation	Preparation of powder agglomerates
EP1033991B1 (en) *	1997-10-09	2002-04-17	Schering Corporation	Mometasone furoate suspensions for nebulization
MY133181A (en) *	1998-09-10	2007-10-31	Schering Corp	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB9904919D0 (en)	1999-03-03	1999-04-28	Novartis Ag	Organic compounds
SE9900833D0 (sv) *	1999-03-09	1999-03-09	Astra Ab	Novel combination
WO2001026658A2 (en) *	1999-10-08	2001-04-19	Schering Corporation	Topical nasal treatment using desloratadine
AR029189A1 (es) *	1999-11-02	2003-06-18	Smithkline Beecham Corp	Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
GB0015876D0 (en)	2000-06-28	2000-08-23	Novartis Ag	Organic compounds
CA2417973A1 (en) *	2000-08-04	2002-02-14	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration
CN101518537A (zh) *	2000-12-22	2009-09-02	日本新药株式会社	炎症性呼吸道疾病的预防/治疗剂
GB0207906D0 (en)	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
WO2005030220A1 (en) *	2003-09-26	2005-04-07	Schering Corporation	Pulmonary disease treatment
WO2005037245A2 (en) *	2003-10-21	2005-04-28	Direct-Haler A/S	A multiple route medication for the treatment of rhinitis and asthma
WO2005044187A2 (en) *	2003-10-28	2005-05-19	Glaxo Group Limited	Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
EP1711164B1 (en) *	2004-01-21	2010-03-24	Schering Corporation	Method of treating acute rhinosinusitis
US7858650B2 (en)	2004-10-22	2010-12-28	Ono Pharmaceutical Co., Ltd.	Medicinal composition for inhalation
US8679545B2 (en)	2005-11-12	2014-03-25	The Regents Of The University Of California	Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en)	2005-11-12	2012-12-04	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090143343A1 (en)	2007-11-13	2009-06-04	Meritage Pharma, Inc.	Compositions for the treatment of inflammation of the gastrointestinal tract
KR101245604B1 (ko)	2007-11-13	2013-03-21	메리테이지 파마, 인크.	코르티코스테로이드 조성물
WO2010013240A1 (en)	2008-07-31	2010-02-04	Dekel Pharmaceuticals Ltd.	Compositions and methods for treating inflammatory disorders
LT2328553T (lt) *	2008-08-20	2020-09-10	The Regents Of The University Of California	Kortikosteroidai, skirti virškinimo trakto uždegiminių ligų gydymui
AR073796A1 (es) *	2008-10-10	2010-12-01	Schering Corp	Formulaciones de corticosteroides y sus metodos de tratamiento
US9370483B2 (en)	2013-09-13	2016-06-21	Glenmark Specialty S.A.	Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9937189B2 (en)	2013-09-13	2018-04-10	Glenmark Specialty S.A.	Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10548907B2 (en)	2013-10-04	2020-02-04	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10758550B2 (en)	2013-10-04	2020-09-01	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10016443B2 (en)	2013-10-04	2018-07-10	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
RU2686670C2 (ru)	2013-10-04	2019-04-30	Гленмарк Спешиалити С.А.	Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
US10653661B2 (en)	2013-10-04	2020-05-19	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US11679210B2 (en)	2014-10-03	2023-06-20	Glenmark Specialty S.A.	Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107260665B (zh) *	2016-04-08	2021-03-30	天津金耀集团有限公司	一种吸入用糠酸莫米松混悬液组合物
MX2020008741A (es)	2018-02-23	2020-09-28	Glenmark Specialty Sa	Tratamiento de la rinitis alergica en sujetos pediatricos con una combinacion de mometasona y olopatadina.
US12303635B2 (en)	2018-04-16	2025-05-20	Glenmark Specialty S.A.	Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN113933415B (zh) *	2021-09-30	2023-03-24	北京阳光德美医药科技有限公司	一种hplc-ms/ms测定人血浆中糠酸酯浓度的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3260474D1 (en)	1981-02-02	1984-09-06	Schering Corp	Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
KR890000664B1 (ko) *	1981-10-19	1989-03-22	바리 안소니 뉴우샘	미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4731447A (en)	1985-05-13	1988-03-15	Schering Corporation	Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4972830A (en)	1985-07-31	1990-11-27	Vortran Medical Technology, Inc.	Inhalation device and method
US4873335A (en)	1986-03-12	1989-10-10	Schering Corporation	3-phenethyl-2-benzene-amides or aza-derivatives thereof
US4910192A (en) *	1987-12-04	1990-03-20	Sri International	Topically active steroidal anti-inflammatory agents
ES2087911T3 (es) *	1989-04-28	1996-08-01	Riker Laboratories Inc	Dispositivo de inhalacion de polvo seco.
ES2071306T3 (es) *	1990-03-23	1995-06-16	Minnesota Mining & Mfg	El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
PL165803B1 (pl) *	1990-09-10	1995-02-28	Schering Corp	Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
CA2091354C (en) *	1990-10-16	2005-04-12	John Lezdey	Treatment of inflammation
AU658854B2 (en) *	1990-10-18	1995-05-04	Minnesota Mining And Manufacturing Company	Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9105705D0 (en) *	1991-03-18	1991-05-01	Sandoz Ltd	Improvements in or relating to organic compounds
ATE226067T1 (de) *	1991-06-10	2002-11-15	Schering Corp	Fluorchlorkohlenwasserstofffreie aerosolformulierungen
SK140493A3 (en) *	1991-06-10	1994-10-05	Schering Corp	Non-chlorofluorocarbon aerosol formulations
DK0592601T3 (da) *	1991-06-26	1996-06-10	Schering Corp	Inhalationsindretning til medikamenter i pulverform
DE4140689B4 (de) *	1991-12-10	2007-11-22	Boehringer Ingelheim Kg	Inhalationspulver und Verfahren zu ihrer Herstellung
ATE171865T1 (de) *	1991-12-12	1998-10-15	Glaxo Group Ltd	Arzneimittel
ES2079210T3 (es) *	1991-12-12	1996-01-01	Glaxo Group Ltd	Formulacion farmaceutica de aerosol.
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
JP2736168B2 (ja) *	1992-03-10	1998-04-02	フアイソンズ・ピーエルシー	医薬製剤
GB9207400D0 (en) *	1992-04-02	1992-05-13	Smithkline Beecham Plc	Novel use
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

1995
- 1995-01-24 PE PE1995260142A patent/PE44995A1/es not_active Application Discontinuation
- 1995-01-26 DE DE69526425T patent/DE69526425T2/de not_active Expired - Lifetime
- 1995-01-26 IL IL11245995A patent/IL112459A/xx not_active IP Right Cessation
- 1995-01-26 TW TW084100705A patent/TW329387B/zh not_active IP Right Cessation
- 1995-01-26 EP EP09007995A patent/EP2156840B1/en not_active Expired - Lifetime
- 1995-01-26 ES ES09007995T patent/ES2369516T3/es not_active Expired - Lifetime
- 1995-01-26 EP EP95909242A patent/EP0740550B1/en not_active Expired - Lifetime
- 1995-01-26 EP EP01119615A patent/EP1192946A1/en not_active Ceased
- 1995-01-26 SK SK822-96A patent/SK283338B6/sk not_active IP Right Cessation
- 1995-01-26 PT PT09007995T patent/PT2156840E/pt unknown
- 1995-01-26 CO CO95002738A patent/CO4340692A1/es unknown
- 1995-01-26 EP EP02001144A patent/EP1201242B1/en not_active Expired - Lifetime
- 1995-01-26 AT AT01119614T patent/ATE525075T1/de not_active IP Right Cessation
- 1995-01-26 CN CNB951913603A patent/CN100358528C/zh not_active Expired - Lifetime
- 1995-01-26 NZ NZ279979A patent/NZ279979A/en not_active IP Right Cessation
- 1995-01-26 AT AT09007995T patent/ATE519489T1/de active
- 1995-01-26 MX MX9602246A patent/MX9602246A/es active IP Right Grant
- 1995-01-26 SG SG1996000423A patent/SG47387A1/en unknown
- 1995-01-26 ES ES95909242T patent/ES2173947T3/es not_active Expired - Lifetime
- 1995-01-26 AU AU17271/95A patent/AU691880B2/en not_active Expired
- 1995-01-26 AT AT95909242T patent/ATE216243T1/de active
- 1995-01-26 AT AT02001144T patent/ATE531364T1/de active
- 1995-01-26 CN CNB2004100324736A patent/CN100441192C/zh not_active Expired - Lifetime
- 1995-01-26 CN CNA2007101867131A patent/CN101156860A/zh active Pending
- 1995-01-26 DK DK95909242T patent/DK0740550T3/da active
- 1995-01-26 CA CA002182086A patent/CA2182086C/en not_active Expired - Lifetime
- 1995-01-26 EP EP01119613A patent/EP1174138B1/en not_active Expired - Lifetime
- 1995-01-26 DK DK09007995.5T patent/DK2156840T3/da active
- 1995-01-26 EP EP01119614A patent/EP1174139B1/en not_active Expired - Lifetime
- 1995-01-26 CZ CZ962191A patent/CZ219196A3/cs unknown
- 1995-01-26 JP JP52007495A patent/JP3480736B2/ja not_active Expired - Lifetime
- 1995-01-26 PT PT01119613T patent/PT1174138E/pt unknown
- 1995-01-26 KR KR1019960704076A patent/KR100234864B1/ko not_active Expired - Lifetime
- 1995-01-26 PL PL95315575A patent/PL315575A1/xx unknown
- 1995-01-26 ES ES01119613T patent/ES2368827T3/es not_active Expired - Lifetime
- 1995-01-26 HU HU9602043A patent/HU227837B1/hu unknown
- 1995-01-26 CN CNA2007101867146A patent/CN101164542A/zh active Pending
- 1995-01-26 PT PT95909242T patent/PT740550E/pt unknown
- 1995-01-26 ZA ZA95637A patent/ZA95637B/xx unknown
- 1995-01-26 AT AT01119613T patent/ATE518520T1/de active
- 1995-01-26 WO PCT/US1995/000550 patent/WO1995020393A1/en not_active Ceased
- 1995-01-26 DK DK01119613.6T patent/DK1174138T3/da active
- 1995-01-27 MY MYPI95000213A patent/MY114665A/en unknown
1996
- 1996-07-12 FI FI962828A patent/FI122395B/fi not_active IP Right Cessation
- 1996-07-26 NO NO19963132A patent/NO314535B1/no not_active IP Right Cessation
1998
- 1998-11-30 JP JP10340817A patent/JPH11286447A/ja not_active Withdrawn
2002
- 2002-02-27 HK HK02101491.0A patent/HK1040912A1/en unknown
- 2002-02-27 HK HK02101490.1A patent/HK1040911B/en not_active IP Right Cessation
- 2002-04-08 HK HK02102575.7A patent/HK1040918A1/en unknown
- 2002-05-21 HK HK02103767.3A patent/HK1041829A1/en unknown
- 2002-10-17 NO NO20025002A patent/NO328698B1/no not_active IP Right Cessation
2003
- 2003-06-03 JP JP2003158657A patent/JP2003313128A/ja not_active Withdrawn
2007
- 2007-10-19 JP JP2007273211A patent/JP2008031184A/ja not_active Withdrawn
2008
- 2008-07-02 JP JP2008174020A patent/JP5247265B2/ja not_active Expired - Lifetime
2011
- 2011-07-08 FI FI20115742A patent/FI123580B/fi not_active IP Right Cessation
- 2011-10-27 CY CY1100007A patent/CY2617B2/xx unknown
- 2011-10-27 CY CY1100006A patent/CY2616B2/xx unknown
- 2011-11-09 JP JP2011245814A patent/JP2012036222A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
HK1041829A1 (en)	2002-07-26
KR100234864B1 (ko)	1999-12-15
EP1174139B1 (en)	2011-09-21
CN100441192C (zh)	2008-12-10
SG47387A1 (en)	1998-04-17
AU691880B2 (en)	1998-05-28
JP2003313128A (ja)	2003-11-06
PT1174138E (pt)	2011-10-03
NO314535B1 (no)	2003-04-07
FI20115742L (fi)	2011-07-08
JP2008285497A (ja)	2008-11-27
CN1139384A (zh)	1997-01-01
CN101164542A (zh)	2008-04-23
EP0740550B1 (en)	2002-04-17
EP1201242A2 (en)	2002-05-02
ATE525075T1 (de)	2011-10-15
PT740550E (pt)	2002-08-30
SK283338B6 (sk)	2003-06-03
EP1201242B1 (en)	2011-11-02
ATE519489T1 (de)	2011-08-15
CZ219196A3 (en)	1996-12-11
CA2182086C (en)	2000-04-11
ES2173947T3 (es)	2002-11-01
HK1040918A1 (en)	2002-06-28
HK1040912A1 (en)	2002-06-28
ES2369516T3 (es)	2011-12-01
EP1174138B1 (en)	2011-08-03
NO963132L (no)	1996-09-26
MX9602246A (es)	1997-07-31
ATE216243T1 (de)	2002-05-15
ATE518520T1 (de)	2011-08-15
ATE531364T1 (de)	2011-11-15
JP2012036222A (ja)	2012-02-23
JP2008031184A (ja)	2008-02-14
HK1040911A1 (en)	2002-06-28
HUT74884A (en)	1997-02-28
NO20025002L (no)	1996-09-26
JPH11286447A (ja)	1999-10-19
AU1727195A (en)	1995-08-15
EP2156840A3 (en)	2010-05-19
CY2616B2 (en)	2012-05-23
HU227837B1 (en)	2012-05-02
IL112459A0 (en)	1995-03-30
EP0740550A1 (en)	1996-11-06
TW329387B (en)	1998-04-11
DE69526425T2 (de)	2002-12-05
EP1174139A2 (en)	2002-01-23
EP2156840A2 (en)	2010-02-24
CN1531967A (zh)	2004-09-29
EP2156840B1 (en)	2011-08-10
DK2156840T3 (da)	2011-11-21
EP1174138A3 (en)	2002-01-30
ES2368827T3 (es)	2011-11-22
JP3480736B2 (ja)	2003-12-22
PT2156840E (pt)	2011-10-18
EP1174138A2 (en)	2002-01-23
JPH09501700A (ja)	1997-02-18
FI123580B (fi)	2013-07-31
HK1135331A1 (en)	2010-06-04
HK1040911B (en)	2011-11-18
DK1174138T3 (da)	2011-11-21
FI962828A0 (fi)	1996-07-12
IL112459A (en)	1999-04-11
DE69526425D1 (de)	2002-05-23
CY2617B2 (en)	2012-05-23
JP5247265B2 (ja)	2013-07-24
NO328698B1 (no)	2010-04-26
CN101156860A (zh)	2008-04-09
NO963132D0 (no)	1996-07-26
SK82296A3 (en)	1997-03-05
NO20025002D0 (no)	2002-10-17
MY114665A (en)	2002-12-31
FI962828L (fi)	1996-07-12
CO4340692A1 (es)	1996-07-30
HU9602043D0 (en)	1996-09-30
NZ279979A (en)	2001-03-30
PL315575A1 (en)	1996-11-12
CN100358528C (zh)	2008-01-02
WO1995020393A1 (en)	1995-08-03
CA2182086A1 (en)	1995-08-03
ZA95637B (en)	1995-07-26
PE44995A1 (es)	1995-12-18
EP1174139A3 (en)	2002-01-30
EP1201242A3 (en)	2003-12-03
FI122395B (fi)	2011-12-30
EP1192946A1 (en)	2002-04-03

Publication	Publication Date	Title
DK0740550T3 (da)	2002-06-24	Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger
CY1109030T1 (el)	2014-07-02	Συνθεση για εισπνοη
GR3022083T3 (en)	1997-03-31	Inhalant based on taurine
Blanco et al.	2001	AD Loppow et al.
Heath et al.	1998	Information from your family doctor: Taking care of chronic bronchitis
WO1992011025A3 (en)	1992-09-17	Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases